CAMP4 Therapeutics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Kendall Sq Fl 3 Bldg 1400, Cambridge, ...Phone Number
(617) 763-3412Website
www.camp4tx.comRevenue
<$5 MillionStock Symbol
CAMPIndustry
About CAMP4 Therapeutics
CAMP4 Therapeutics Org Chart
Is CAMP4 Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if CAMP4 Therapeutics had a recent Job posting/layoffs
Check out if CAMP4 Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if CAMP4 Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when CAMP4 Therapeutics launches new products
CAMP4 Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at CAMP4 Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once CAMP4 Therapeutics has new funding data
Earning: See what the market has to say on CAMP4 Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined CAMP4 Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to CAMP4 Therapeutics
Compare insights from companies similar to CAMP4 Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CAMP4 Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CAMP4 Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CAMP4 Therapeutics.
CAMP4 Therapeutics financials insights
Gather financial insights about CAMP4 Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$30M
Other Financing Round
$45M
Series B
$100M
CAMP4 Therapeutics Tech Stack
A closer look at the technologies used by CAMP4 Therapeutics
Most Recent Scoops
CAMP4 Therapeutics News & Media
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
Proceeds of $50.1 million will be used to support the Company’s advancement of CMP-002 for the treatment of SYNGAP1-related disorder Proceeds of $50.1 million will be used to support the Company’s advancement of CMP-002 for the treatment of SYNGAP1-related disorderCAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
Planned first-in-human clinical trial to assess a disease modifying intervention for patients with SYNGAP1-related disorderCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that on July 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted a non-
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding CAMP4 Therapeutics
At CAMP4 Therapeutics, we are revolutionizing drug discovery and development to be faster, smarter and better. With our Gene Circuitry Platform, we have discovered how to dial up or dial down the expression of any gene. Using the foundational insights enabled by our platform, we are pioneering a systematic and scalable approach to discover new, dru... Read More

